Lantern Pharma Inc.
Related Filers (35)
- Bios Equity Partners, LP (11)
- Kreis Leslie W. (8)
- Fletcher Aaron G.L. (8)
- Cavu Management, LP (8)
- BIOS Advisors GP, LLC (8)
- Cavu Advisors, LLC (8)
- BIOS Capital Management, LP (8)
- BIOS Fund I, LP (7)
- BIOS Fund I QP, LP (7)
- BP Directors, LP (7)
- BIOS Fund II QP, LP (6)
- BIOS Fund II NT, LP (6)
- BIOS Fund II, LP (6)
- Bios Equity Partners II, LP (6)
- SHARMA PANNA (4)
- Green Park & Golf Ventures, LLC (4)
- KEYSER D JEFFREY (4)
- Asaithambi Arunkumar (3)
- Health Wildcatters Fund II, LLC (3)
- Heighten Clay M (3)
- Green Park & Golf Ventures II, LLC (3)
- Lantern 3-19 Investment, LLC (3)
- Health Wildcatters, LLC (3)
- Soderstrom Carl D (3)
- GPG LPI Investment, LLC (3)
- Garcia Gilbert G. II (3)
- Bhatia Kishor G. (3)
- Margrave David R. (3)
- Chandru Vijay (3)
- Silberstein David S. (3)
- PRENDERGAST FRANKLYN G (3)
- BIOLOGICAL MIMETICS INC (2)
- Empery Asset Management, LP (2)
- Maccecchini Maria-Luisa (2)
- ProPhase Labs, Inc. (2)
- Show More ...
Financials (14)
10-Q
Wednesday, 11/8/2023
Quarterly Report for period ending 2023-09-30
10-Q
Wednesday, 8/9/2023
Quarterly Report for period ending 2023-06-30
10-Q
Tuesday, 5/9/2023
Quarterly Report for period ending 2023-03-31
10-K
Monday, 3/20/2023
Annual Report for period ending 2022-12-31
10-Q
Monday, 11/7/2022
Quarterly Report for period ending 2022-09-30
10-Q
Monday, 8/8/2022
Quarterly Report for period ending 2022-06-30
10-Q
Tuesday, 5/3/2022
Quarterly Report for period ending 2022-03-31
10-K
Thursday, 3/10/2022
Annual Report for period ending 2021-12-31
10-Q
Monday, 11/1/2021
Quarterly Report for period ending 2021-09-30
10-Q
Thursday, 7/29/2021
Quarterly Report for period ending 2021-06-30
10-Q
Monday, 5/3/2021
Quarterly Report for period ending 2021-03-31
10-K
Wednesday, 3/10/2021
Annual Report for period ending 2020-12-31
10-Q
Thursday, 10/29/2020
Quarterly Report for period ending 2020-09-30
10-Q
Thursday, 7/30/2020
Quarterly Report for period ending 2020-06-30
News (30)
8-K
Friday, 12/29/2023
Current report filing
8-K
Friday, 11/24/2023
Current report filing
8-K
Wednesday, 11/8/2023
Current report filing
8-K
Friday, 10/20/2023
Current report filing
8-K
Wednesday, 8/9/2023
Current report filing
8-K
Wednesday, 6/21/2023
Current report filing
8-K
Tuesday, 5/9/2023
Current report filing
8-K
Monday, 3/20/2023
Current report filing
8-K
Wednesday, 1/18/2023
Current report filing
8-K
Monday, 11/7/2022
Current report filing
8-K
Monday, 8/8/2022
Current report filing
8-K
Tuesday, 6/14/2022
Current report filing
8-K
Tuesday, 5/3/2022
Current report filing
8-K
Tuesday, 4/26/2022
Current report filing
8-K
Monday, 4/25/2022
Current report filing
8-K
Tuesday, 3/22/2022
Current report filing
8-K
Thursday, 3/10/2022
Current report filing
8-K
Monday, 1/24/2022
Current report filing
8-K
Monday, 11/22/2021
Current report filing
8-K
Monday, 11/1/2021
Current report filing
8-K
Thursday, 7/29/2021
Current report filing
8-K
Tuesday, 5/25/2021
Current report filing
8-K
Monday, 5/3/2021
Current report filing
8-K
Wednesday, 3/10/2021
Current report filing
8-K
Wednesday, 1/6/2021
Current report filing
8-K
Thursday, 10/29/2020
Current report filing
8-K
Friday, 8/21/2020
Current report filing
8-K
Thursday, 7/30/2020
Current report filing
8-K
Thursday, 7/16/2020
Current report filing
8-K
Wednesday, 6/17/2020
Current report filing
Other (19)
ARS
Friday, 5/5/2023
Annual report to security holders
EFFECT
Monday, 7/12/2021
Notice of Effectiveness
CORRESP
Thursday, 7/8/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Thursday, 1/14/2021
Notice of Effectiveness
CORRESP
Monday, 1/11/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 1/8/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Tuesday, 6/16/2020
None
EFFECT
Wednesday, 6/10/2020
Notice of Effectiveness
8-A12B
Monday, 6/8/2020
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CERT
Monday, 6/8/2020
Certification by an exchange approving securities for listing
CORRESP
Monday, 6/8/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 6/8/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 6/2/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 5/22/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 5/12/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 4/16/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Friday, 2/21/2020
None
D
Monday, 3/18/2019
Exempt (Private) Offering
D
Monday, 1/14/2019
Exempt (Private) Offering
Ownership (55)
SC 13G/A
Wednesday, 2/14/2024
ProPhase Labs, Inc.: Major Shareholders
4
Friday, 1/19/2024
BIOS Fund I, LP: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2024
Cavu Advisors, LLC: Statement of changes in beneficial ownership of securities
4
Friday, 12/1/2023
Cavu Advisors, LLC: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 12/1/2023
Bios Equity Partners, LP: Major Shareholders
4
Friday, 12/1/2023
BIOS Fund I, LP: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 11/21/2022
ProPhase Labs, Inc.: Major Shareholders
4
Wednesday, 11/9/2022
Cavu Advisors, LLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/9/2022
BIOS Fund I, LP: Statement of changes in beneficial ownership of securities
4
Monday, 10/24/2022
Maccecchini Maria-Luisa: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/7/2022
Cavu Advisors, LLC: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/7/2022
BIOS Fund I, LP: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/9/2022
SHARMA PANNA: Statement of changes in beneficial ownership of securities
3
Friday, 6/17/2022
Maccecchini Maria-Luisa: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 3/22/2022
Bios Equity Partners, LP: Major Shareholders
4
Monday, 3/21/2022
BIOS Fund I, LP: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 1/11/2022
Empery Asset Management, LP: Major Shareholders
4
Monday, 11/8/2021
Silberstein David S.: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
Chandru Vijay: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
BP Directors, LP: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
PRENDERGAST FRANKLYN G: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
KEYSER D JEFFREY: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/2/2021
Margrave David R.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/2/2021
Bhatia Kishor G.: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 2/16/2021
Asaithambi Arunkumar: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Green Park & Golf Ventures, LLC: Major Shareholders
SC 13G
Monday, 1/25/2021
Empery Asset Management, LP: Major Shareholders
4
Tuesday, 1/19/2021
Green Park & Golf Ventures II, LLC: Statement of changes in beneficial ownership of securities
SC 13D
Tuesday, 6/23/2020
Bios Equity Partners, LP: Major Shareholders
SC 13D
Tuesday, 6/23/2020
BIOLOGICAL MIMETICS INC: Major Shareholders
SC 13D
Friday, 6/19/2020
SHARMA PANNA: Major Shareholders
4
Wednesday, 6/17/2020
Green Park & Golf Ventures II, LLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2020
BP Directors, LP: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2020
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
Chandru Vijay: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
Bhatia Kishor G.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
KEYSER D JEFFREY: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
KEYSER D JEFFREY: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
SHARMA PANNA: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
Asaithambi Arunkumar: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
Silberstein David S.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
PRENDERGAST FRANKLYN G: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
Margrave David R.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/10/2020
PRENDERGAST FRANKLYN G: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
Silberstein David S.: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
Chandru Vijay: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
SHARMA PANNA: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
Green Park & Golf Ventures II, LLC: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
Margrave David R.: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
BP Directors, LP: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
BIOLOGICAL MIMETICS INC: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
Asaithambi Arunkumar: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
KEYSER D JEFFREY: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
Bhatia Kishor G.: Initial statement of beneficial ownership of securities
3
Wednesday, 6/10/2020
BIOS Advisors GP, LLC: Initial statement of beneficial ownership of securities
Prospectus (16)
S-3
Friday, 7/2/2021
Registration statement for specified transactions by certain issuers
424B4
Friday, 1/15/2021
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Friday, 1/15/2021
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
FWP
Monday, 1/11/2021
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1
Friday, 1/8/2021
General form of registration statement for all companies including face-amount certificate companies
DRS
Wednesday, 12/16/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 12/15/2020
Correspondence Related to Draft Registration Statement
S-1MEF
Friday, 6/12/2020
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
424B4
Friday, 6/12/2020
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Monday, 6/8/2020
General form of registration statement for all companies including face-amount certificate companies
FWP
Tuesday, 5/19/2020
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1/A
Tuesday, 5/19/2020
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 5/12/2020
General form of registration statement for all companies including face-amount certificate companies
S-1
Thursday, 4/16/2020
General form of registration statement for all companies including face-amount certificate companies
DRSLTR
Friday, 1/24/2020
Correspondence Related to Draft Registration Statement
DRS
Friday, 1/24/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (5)
DEF 14A
Friday, 4/28/2023
Definitive proxy statements
DEFA14A
Tuesday, 5/3/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Wednesday, 4/27/2022
Definitive proxy statements
DEF 14A
Friday, 4/9/2021
Definitive proxy statements
DEFA14A
Friday, 4/9/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.